Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University. Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Steven A. Wyatt, DO. Adjunct faculty, University of North Carolina at Charlotte. Dr. Wyatt has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Kali D. Cyrus, MD, MPH
Assistant professor, Department of Psychiatry, Johns Hopkins Medicine, Baltimore, MD. Physician-activist in private practice, Washington, DC.
Dr. Cyrus has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Edmund S. Higgins, MD. Clinical associate professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina. Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
